Schrodinger

SDGR · NASDAQ

$23.40+$0.28 (+1.21%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $23.12

Latest news

Press releaseOct 14, 11:05 AM ETBusiness Wire
Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
NewsSep 29, 4:32 PM ETChris Katje
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You
Press releaseSep 17, 8:30 AM ETBusiness Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press releaseSep 14, 10:00 AM ETPRNewswire
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
Press releaseSep 9, 7:00 AM ETBusiness Wire
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
Press releaseSep 3, 8:55 AM ETPRNewswire
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
Press releaseSep 1, 8:30 AM ETBusiness Wire
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
Press releaseAug 14, 8:30 AM ETBusiness Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press releaseAug 10, 9:10 AM ETGlobe Newswire
AI Found an Influenza Target That Survives Viral Mutation
Press releaseAug 5, 4:05 PM ETBusiness Wire
Schrödinger Reports Second Quarter 2026 Financial Results
Press releaseAug 5, 8:30 AM ETBusiness Wire
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
Press releaseJul 27, 7:30 AM ETBusiness Wire
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
Press releaseJul 23, 9:05 AM ETPRNewswire
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
Press releaseJul 22, 8:30 AM ETBusiness Wire
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5
Press releaseJul 20, 8:30 AM ETBusiness Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press releaseJul 1, 9:00 AM ETPRNewswire
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
NewsJul 1, 7:50 AM ETSurbhi Jain
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
Press releaseJun 18, 8:30 AM ETBusiness Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press releaseJun 16, 8:45 AM ETPRNewswire
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
Press releaseMay 22, 8:30 AM ETBusiness Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press releaseMay 5, 4:05 PM ETBusiness Wire
Schrödinger Reports First Quarter 2026 Financial Results
NewsMay 5, 7:12 AM ET
Earnings Scheduled For May 5, 2026
Press releaseMay 4, 8:30 AM ETBusiness Wire
Schrödinger to Participate in Upcoming Investor Conferences
Press releaseApr 21, 8:30 AM ETBusiness Wire
Schrödinger to Announce First Quarter 2026 Financial Results on May 5
Press releaseApr 17, 8:30 AM ETBusiness Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press releaseMar 18, 8:30 AM ETBusiness Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press releaseFeb 25, 4:05 PM ETBusiness Wire
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results
NewsFeb 25, 6:11 AM ET
Earnings Scheduled For February 25, 2026
NewsFeb 24, 1:02 PM ET
Earnings Preview For Schrodinger
Press releaseFeb 24, 8:30 AM ETBusiness Wire
Schrödinger to Participate in Upcoming Investor Conferences
NewsFeb 19, 6:21 AM ETAvi Kapoor
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1
Press releaseJan 29, 9:25 AM ETPRNewswire
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
Press releaseJan 12, 8:30 AM ETBusiness Wire
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
NewsNov 5, 6:12 AM ET
Earnings Scheduled For November 5, 2025
NewsNov 3, 12:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session
NewsSep 30, 10:01 AM ET
Expert Outlook: Schrodinger Through The Eyes Of 5 Analysts
NewsAug 18, 5:03 PM ET
What 4 Analyst Ratings Have To Say About Schrodinger
NewsAug 15, 10:53 AM ETAvi Kapoor
This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry

Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

AI Found an Influenza Target That Survives Viral Mutation

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data

Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports First Quarter 2026 Financial Results

Earnings Scheduled For May 5, 2026

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Earnings Scheduled For February 25, 2026

Earnings Preview For Schrodinger

Schrödinger to Participate in Upcoming Investor Conferences

Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1

AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

Earnings Scheduled For November 5, 2025

10 Health Care Stocks Whale Activity In Today's Session

Expert Outlook: Schrodinger Through The Eyes Of 5 Analysts

What 4 Analyst Ratings Have To Say About Schrodinger

This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday